Benfluorex
- Generic Name
- Benfluorex
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H20F3NO2
- CAS Number
- 23602-78-0
- Unique Ingredient Identifier
- 403FO0NQG3
- Background
Benfluorex is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It was patented and manufactured by a French pharmaceutical company Servier. The European Medicines Agency (EMA) recommended withdrawing all benfluorex containing medicines on 18 December 2009. This recommendation was based on the risks (especially fenfluramine-like cardiovascular side-effects) outweighing the benefits.
- Associated Conditions
- -
- Associated Therapies
- -
Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- Air Force Military Medical University, China
- Target Recruit Count
- 240
- Registration Number
- NCT00544518
- Locations
- 🇨🇳
XiJing hospital of Fourth Military Medical University, Xi'an, Shanxi, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath